Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Coherus Oncology (CHRS) over the last 12 years, with Q3 2025 value amounting to 0.58.

  • Coherus Oncology's Asset Utilization Ratio rose 21109.67% to 0.58 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58, marking a year-over-year increase of 21109.67%. This contributed to the annual value of 0.5 for FY2024, which is 688.74% up from last year.
  • As of Q3 2025, Coherus Oncology's Asset Utilization Ratio stood at 0.58, which was up 21109.67% from 0.67 recorded in Q2 2025.
  • Coherus Oncology's Asset Utilization Ratio's 5-year high stood at 0.67 during Q2 2025, with a 5-year trough of 0.19 in Q3 2024.
  • Over the past 5 years, Coherus Oncology's median Asset Utilization Ratio value was 0.46 (recorded in 2021), while the average stood at 0.46.
  • As far as peak fluctuations go, Coherus Oncology's Asset Utilization Ratio plummeted by 5339.57% in 2024, and later soared by 21109.67% in 2025.
  • Coherus Oncology's Asset Utilization Ratio (Quarter) stood at 0.46 in 2021, then fell by 10.98% to 0.41 in 2022, then increased by 3.65% to 0.42 in 2023, then surged by 32.06% to 0.56 in 2024, then rose by 3.77% to 0.58 in 2025.
  • Its Asset Utilization Ratio stands at 0.58 for Q3 2025, versus 0.67 for Q2 2025 and 0.66 for Q1 2025.